415 related articles for article (PubMed ID: 16773687)
1. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
[TBL] [Abstract][Full Text] [Related]
3. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.
Kamada K; Kitamoto M; Aikata H; Kawakami Y; Kono H; Imamura M; Nakanishi T; Chayama K
Am J Surg; 2002 Sep; 184(3):284-90. PubMed ID: 12354601
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
6. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
[TBL] [Abstract][Full Text] [Related]
7. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
[TBL] [Abstract][Full Text] [Related]
10. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.
Becker G; Soezgen T; Olschewski M; Laubenberger J; Blum HE; Allgaier HP
World J Gastroenterol; 2005 Oct; 11(39):6104-9. PubMed ID: 16273634
[TBL] [Abstract][Full Text] [Related]
11. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
[TBL] [Abstract][Full Text] [Related]
12. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients.
Huang YH; Wu JC; Chau GY; Lui WY; King KL; Chiang JH; Yen SH; Sheng WY; Hou MC; Lu CL; Chang FY; Lee SD
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):315-21. PubMed ID: 10333206
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma.
Kirchhoff T; Chavan A; Galanski M
Eur J Gastroenterol Hepatol; 1998 Nov; 10(11):907-9. PubMed ID: 9872610
[TBL] [Abstract][Full Text] [Related]
14. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
Tanaka K; Nakamura S; Numata K; Kondo M; Morita K; Kitamura T; Saito S; Kiba T; Okazaki H; Sekihara H
Cancer; 1998 Jan; 82(1):78-85. PubMed ID: 9428482
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre.
Molinari M; Kachura JR; Dixon E; Rajan DK; Hayeems EB; Asch MR; Benjamin MS; Sherman M; Gallinger S; Burnett B; Feld R; Chen E; Greig PD; Grant DR; Knox JJ
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):684-92. PubMed ID: 17100154
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation.
Mishra G; Dev A; Paul E; Cheung W; Koukounaras J; Jhamb A; Marginson B; Lim BG; Simkin P; Borsaru A; Burnes J; Goodwin M; Ramachandra V; Spanger M; Lubel J; Gow P; Sood S; Thompson A; Ryan M; Nicoll A; Bell S; Majeed A; Kemp W; Roberts SK;
BMC Cancer; 2020 May; 20(1):483. PubMed ID: 32471447
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Agarwal A; Yadav AK; Kumar A; Gupta S; Panwala HK; Redhu N; Hariprasad S; Ranjan P; Arora A; Gupta A
Indian J Gastroenterol; 2015 Mar; 34(2):117-26. PubMed ID: 25937484
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
